1. bookVolume 60 (2022): Issue 1 (March 2022)
Journal Details
License
Format
Journal
eISSN
2501-062X
First Published
30 Mar 2015
Publication timeframe
4 times per year
Languages
English
access type Open Access

Lupus-related protein-losing enteropathy associated with pseudo-pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine

Published Online: 17 Mar 2022
Page range: 85 - 89
Received: 26 May 2021
Journal Details
License
Format
Journal
eISSN
2501-062X
First Published
30 Mar 2015
Publication timeframe
4 times per year
Languages
English
Abstract

We herein report the first case of lupus-related protein-losing enteropathy associated with pseudo-pseudo Meigs’ syndrome. Lupus-related protein-losing enteropathy and pseudo-pseudo Meigs’ syndrome are extremely rare complications in patients with systemic lupus erythematosus, Both have a similar clinical course characterized by producing marked ascites, and respond to steroids in typical cases. However, in our case, steroid monotherapy was inadequate and the addition of hydroxychloroquine was effective for their treatment. Furthermore, no reports have previously confirmed elevated CA 125 levels with lupus-related protein-losing enteropathy or increased 99mTc-HSA activity with pseudo-pseudo Meigs’ syndrome. In addition, we are the first to report an evaluation of the histopathology of lupus-related protein-losing enteropathy. Previously reported cases have been described as being caused by either pseudo-Meigs’s syndrome or lupus-related protein-losing enteropathy as the cause of the rare pathology that causes marked pleural effusion and ascites in patients with systemic lupus erythematosus, but it has not been evaluated whether the other is co-occurring. Our case highlights that there is a potential case of overlapping lupus-related protein-losing enteropathy and pseudo-Pseudo-Meigs’s syndrome. Furthermore, it is possible that patients with marked ascites with elevated CA 125 levels were mistakenly diagnosed with Meigs’s syndrome or pseudo-Meigs’s syndrome associated with malignant or benign ovarian tumors and underwent surgery. Clinicians should not forget SLE with pseudo-Pseudo-Meigs’s syndrome as one of the differential diagnoses for marked ascites with elevated CA 125 levels.

Keywords

1. ARINGER M., COSTENBADER K., DAIKH D., BRINKS R., MOSCA M., RAMSEY-GOLDMAN R., et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–9.10.1136/annrheumdis-2018-214819Search in Google Scholar

2. AL-MOGAIREN SM. Lupus protein-losing enteropathy (LUPLE): a systematic review. Rheumatol Int. 2011;31(8):995–1001.10.1007/s00296-011-1827-9Search in Google Scholar

3. TIALMA WA. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome. Gynecol Oncol. 2005;97(1):288–91.10.1016/j.ygyno.2004.12.022Search in Google Scholar

4. HOCHBERG MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.10.1002/art.1780400928Search in Google Scholar

5. PETRI M., ORBAI AM., ALARCON GS., GORDON C., MERRILL JT., FORTIN PR., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.10.1002/art.34473Search in Google Scholar

6. YOSHIDA M., MIYATA M., SAKA M., SASAJIMA T., SATO H., TAKIGUCHI J., et al. Protein-losing enteropathy exacerbated with the appearance of symptoms of systemic lupus erythematosus. Intern Med. 2001;40(5):449–53.10.2169/internalmedicine.40.449Search in Google Scholar

7. CHUNG U., OKA M., NAKAGAWA Y., NISHISHITA T., SEKINE N., TANAKA Y., et al. A patient with protein-losing enteropathy associated with systemic lupus erythematosus. Intern Med. 1992;31(4):521–4.10.2169/internalmedicine.31.521Search in Google Scholar

8. WERNER DE CASTRO GR., APPENZRLLER S., BERTOLO MB., COSTALLAT LT. Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide. Rheumatol Int. 2005;25(2):135–8.10.1007/s00296-004-0483-8Search in Google Scholar

9. TANSIR G., KUMAR P., PIUS A., SUNNY SK., SONEJA M. Pseudo-pseudo Meigs’ syndrome: a rare presentation of systemic lupus erythematosus. Reumatismo. 2019;71(2):108–12.10.4081/reumatismo.2019.1140Search in Google Scholar

10. YANG Z., LIANG Y., LI C., ZHONG R. Serum CA125 elevation is independently associated with serositis in SLE patients. Clin Exp Rheumatol. 2012;30(1):93–8.Search in Google Scholar

11. ZEIMET AG., MARTH C., OFFNER FA., OBRIST P, UHL-STEIDL M., FEICHTINGER H. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol. 1996;62(3):384–9.10.1006/gyno.1996.0253Search in Google Scholar

12. LI T, XIE QB. A case report of pseudo-pseudo Meigs’ syndrome. Chin Med J (Engl). 2019;132(12):1497–8.10.1097/CM9.0000000000000231Search in Google Scholar

13. FAVA A, PETRI M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13.10.1016/j.jaut.2018.11.001Search in Google Scholar

14. Health and Labor Sciences Research Grant Subsidy for Intractable Disease Policy Research. Project, Research on autoimmune diseases, Japan college of Rheumatology. Guideline for the management of systemic lupus erythematosus 2019;2019:226-30 (in Japanese)Search in Google Scholar

15. FANOURIAKIS A., KOSTOPOULOU M., ALUNNO A., ARINGER M., BAJEMA I., BOLETIS JN. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45.10.1136/annrheumdis-2019-215089Search in Google Scholar

16. HANAOKA H., IIDA H., KIYOKAWA T., TAKAKUWA Y., KAWAHATA K. Hydroxychloroquine improves the disease activity and allows the reduction of the corticosteroid dose regardless of background treatment in Japanese patients with systemic lupus erythematosus. Intern Med. 2019;58(9):1257–62.10.2169/internalmedicine.1999-18Search in Google Scholar

17. MIYAGAWA I., NAKANO K., NAKAYAMADA S., IWATA S., HANAMI K., FUKUYO S. Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus. Int J Rheum Dis. 2019;22(3):434–42.10.1111/1756-185X.13387Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo